Characterization of NCS1-InsP3R1 Interaction and Its Functional Significance
Overview
Affiliations
Inositol 1,4,5-trisphosphate receptors (InsP3Rs) are endoplasmic reticulum-localized channels that mediate Ca release from the endoplasmic reticulum into the cytoplasm. We previously reported that an EF-hand Ca-binding protein, neuronal calcium sensor 1 (NCS1), binds to the InsP3R and thereby increases channel open probability, an event associated with chemotherapy-induced peripheral neuropathy. However, the exact NCS1-binding site on InsP3R remains unknown. Using protein docking, co-immunoprecipitation, and blocking peptides, we mapped the NCS1-binding site to residues 66-110 on the suppressor domain of InsP3R type 1 (InsP3R1). We also identified Leu-89, a residue in the hydrophobic pocket of NCS1, as being critical for facilitating the NCS1-InsP3R1 interaction. Overexpression of WT NCS1 in MDA-MB231 breast cancer cells increased Ca signaling and survival, whereas overexpression of Leu-89 NCS1 variants decreased Ca signaling and survival, further suggesting the importance of this residue in the NCS1-InsP3R1 interaction. In conclusion, we show that NCS1-InsP3R1 interaction enhances intracellular Ca signaling in cells and can be modulated by altering or occluding the hydrophobic pocket of NCS1. This improved understanding of the NCS1-InsP3R1 interaction may facilitate the development of management strategies for diseases resulting from aberrant NCS1 expression.
Speelman-Rooms F, Vanmunster M, Coughlan A, Hinrichs M, Pontisso I, Barbeau S Biol Open. 2024; 13(4).
PMID: 38661208 PMC: 11070784. DOI: 10.1242/bio.060357.
Calcium-Associated Proteins in Neuroregeneration.
Lisek M, Tomczak J, Boczek T, Zylinska L Biomolecules. 2024; 14(2).
PMID: 38397420 PMC: 10887043. DOI: 10.3390/biom14020183.
Loss of INPP5K attenuates IP-induced Ca responses in the glioblastoma cell line U-251 MG cells.
Loncke J, Luyten T, Ramos A, Erneux C, Bultynck G BBA Adv. 2023; 4:100105.
PMID: 37842182 PMC: 10568277. DOI: 10.1016/j.bbadva.2023.100105.
Ibrahim E, Munshani S, Domenicano I, Rodwin R, Nowak R, Pusztai L PLoS One. 2022; 17(10):e0275648.
PMID: 36206298 PMC: 9543876. DOI: 10.1371/journal.pone.0275648.
Eustace A, Lee M, Colley G, Roban J, Downing T, Buchanan P Cancer Drug Resist. 2022; 5(3):560-576.
PMID: 36176752 PMC: 9511797. DOI: 10.20517/cdr.2022.41.